Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03

  • STATUS
    Recruiting
  • End date
    Dec 31, 2022
  • participants needed
    2
  • sponsor
    Chinese Academy of Medical Sciences
Updated on 22 January 2021

Summary

The investigators aimed to compare elective nodal irradiation versus involved field irradiation with or without concurrent chemotherapy and the addition of consolidation chemotherapy for patients with extensive lymphatic metastasis of esophageal cancer.

Details
Condition IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer
Treatment Paclitaxel, Platinum-Based Drug, SIB-IMRT, Elective Nodal Irradiation (ENI), Involved Field Irradiation (IFI)
Clinical Study IdentifierNCT03328234
SponsorChinese Academy of Medical Sciences
Last Modified on22 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Age<70
Diagnosis of clinical stage T2-4N0-1M1According to UICC 2002
A untreated squamous esophageal carcinoma
Karnofsky performance status(KPS) 70 and Charlson score 3
Adequate organ function
No known history of drug allergy
Blood routine examination : WBC4.0
hepatic and renal function are normal

Exclusion Criteria

Age 70 or 16
Already received the treatment of chemotherapy or radiotherapy
Pregnant or lactating females
Known drug allergy
Without agreement of informed consent form
Insufficient hepatorenal function or Blood routine examination
Severe cardiovascular diseases, diabetes with uncontrolled blood sugar, mental disorders, uncontrolled severe infection, active ulceration which need intervention
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note